The company says the innovation, built on its CoreNhanced BioJourney platform, is designed for beverage and gummy formats.
|Articles|November 17, 2010
Glanbia, Ganeden Partner
Advertisement
Glanbia Nutritionals (Evanston, IL) is now the primary North American distributor of Ganeden Biotech’s Ganeden BC30 probiotic strain. Ganeden, which recently announced its 100th probiotic patent, will capitalize on Glanbia’s vast distribution and warehouse network in North America.
Advertisement
Related to this article
AuraFen, BILVORA, and IMBE debut at SupplySide Global 2026, and the company will also highlight its CaFi digestive health ingredient.
Horphag Research's Sébastien Bornet breaks down the clinical science behind Robuvit, exploring how the caffeine-free French oak extract supports mitochondrial energy, mood stability, and stress resilience.
Todd Harrison, co-chair of the FDA practice group at Venable LLP, explains how California’s AB 2779 changes date-labeling requirements for supplements, why stability testing matters, and how companies can navigate evolving state rules while advocating for federal uniformity.
FDA's final NDI guidance sets identity and safety expectations. See what AHPA and CRN say remains unresolved and what it means for suppliers.
The company plans to present Organicaps capsules in size 0, 25 years of UC-II, and liquid-filled capsule technology.
DolCas Biotech is featuring the turmeric-derived ingredient Curcugen in Mānukora’s Mānuka honey and Numin’s cognitive-support drink.
The company says it will feature studies on vitamin K2, choline, folate, and MSM, along with beverage concepts and a first-time pet corner.
Advertisement
Advertisement
Trending on Nutritional Outlook - Supplement, Food & Beverage Manufacturing Trends
1
CoreFX Launches CreaSHLD-IN Shielded Creatine at SupplySide Global 2026
2
Robuvit for Stress & Mood: How Horphag's Caffeine-Free Oak Extract Targets Fatigue at the Cellular Level
3
Supplement Expiration Dates: California’s AB 2779 and What Comes Next
4
FDA Finalizes NDI Guidance on Identity and Safety Information, Leaving Some Industry Concerns Open
5